newsfilter
← Latest News
PR Newswire·

TransCode Therapeutics Announces Leadership Transition

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced...